Evidence map›Paper›PMID 39401400›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Machine Learning Early Detection of SARS-CoV-2 High-Risk Variants.

Lun Li, Cuiping Li, Na Li, Dong Zou, Wenming Zhao, Hong Luo, Yongbiao Xue, Zhang Zhang, Yiming Bao, Shuhui Song

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Machine Learning Early Detection of SARS-CoV-2 High-Risk Variants.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lun LiChina National Center for Bioinformation, Beijing, 100101, China.ORCID 0000-0003-3242-031X
Cuiping LiChina National Center for Bioinformation, Beijing, 100101, China.
Na LiChina National Center for Bioinformation, Beijing, 100101, China.
Dong ZouChina National Center for Bioinformation, Beijing, 100101, China.
Wenming ZhaoChina National Center for Bioinformation, Beijing, 100101, China.
Hong LuoChina National Center for Bioinformation, Beijing, 100101, China.
Yongbiao XueChina National Center for Bioinformation, Beijing, 100101, China.
Zhang ZhangChina National Center for Bioinformation, Beijing, 100101, China.
Yiming BaoChina National Center for Bioinformation, Beijing, 100101, China.
Shuhui SongChina National Center for Bioinformation, Beijing, 100101, China.ORCID 0000-0003-2409-8770

Funding

Alliance of National and International·Science Organizations for the Belt·and·Road Regions ANSO-CR-KP-2022-09Beijing Municipal Science & Technology Commission, Administrative Commission of Zhongguancun Science Park Z211100002121006Chinese Academy of Sciences XDB38030200Chinese Academy of Sciences Y2021038Ministry of Science and Technology of the People's Republic of China 2023YFC3041500National Key Research & Development Program of China 2021YFF0703703National Key Research & Development Program of China 2023YFC2604400National Natural Science Foundation of China 32170678National Natural Science Foundation of China 32270718
6 · The paper itself

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved many high-risk variants, resulting in repeated COVID-19 waves over the past years. Therefore, accurate early warning of high-risk variants is vital for epidemic prevention and control. However, detecting high-risk variants through experimental and epidemiological research is time-consuming and often lags behind the emergence and spread of these variants. In this study, HiRisk-Detector a machine learning algorithm based on haplotype network, is developed for computationally early detecting high-risk SARS-CoV-2 variants. Leveraging over 7.6 million high-quality and complete SARS-CoV-2 genomes and metadata, the effectiveness, robustness, and generalizability of HiRisk-Detector are validated. First, HiRisk-Detector is evaluated on actual empirical data, successfully detecting all 13 high-risk variants, preceding World Health Organization announcements by 27 days on average. Second, its robustness is tested by reducing sequencing intensity to one-fourth, noting only a minimal delay of 3.8 days, demonstrating its effectiveness. Third, HiRisk-Detector is applied to detect risks among SARS-CoV-2 Omicron variant sub-lineages, confirming its broad applicability and high ROC-AUC and PR-AUC performance. Overall, HiRisk-Detector features powerful capacity for early detection of high-risk variants, bearing great utility for any public emergency caused by infectious diseases or viruses.

Indexed as

COVID-19Machine LearningSARS-CoV-2AlgorithmsGenome, ViralHumanshaplotype networkhigh‐risk variantmachine learningpre‐warningSARS‐CoV‐2

Identifiers

PMID39401400
PMCPMC11615786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.